Literature DB >> 34556484

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.

Caoilfhionn M Connolly1, Teresa Po-Yu Chiang2, Brian J Boyarsky2, Jake A Ruddy2, Mayan Teles2, Jennifer L Alejo2, Allan Massie2, William A Werbel3, Ami A Shah1, Lisa Christopher-Stine1, Jacqueline Garonzik-Wang2, Dorry L Segev4,5, Julie J Paik1.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; vaccination

Mesh：

Substances：

Year:  2021        PMID： 34556484     DOI： 10.1136/annrheumdis-2021-221252

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  26 in total

1.  Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan Teles; Caoilfhionn M Connolly; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Brian J Boyarsky; Ami A Shah; Jemima Albayda; Lisa Christopher-Stine; William A Werbel; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2022-01-17       Impact factor: 19.103

2.  Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort.

Authors:  Daniele Mauro; Antonio Ciancio; Claudio Di Vico; Luana Passariello; Gelsomina Rozza; Maria Dora Pasquale; Ilenia Pantano; Carlo Cannistrà; Laura Bucci; Silvia Scriffignano; Flavia Riccio; Martina Patrone; Giuseppe Scalise; Piero Ruscitti; Maria Vittoria Montemurro; Antonio Giordano; Maria Teresa Vietri; Francesco Ciccia
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

3.  American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.

Authors:  Jeffrey R Curtis; Sindhu R Johnson; Donald D Anthony; Reuben J Arasaratnam; Lindsey R Baden; Anne R Bass; Cassandra Calabrese; Ellen M Gravallese; Rafael Harpaz; Andrew Kroger; Rebecca E Sadun; Amy S Turner; Eleanor Anderson Williams; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2022-05       Impact factor: 15.483

4.  SARS-CoV-2 Vaccination in Kidney Transplant Recipients-Stratified Analysis of the Humoral Immune Response.

Authors:  Alexander Lammert; Peter Schnuelle; Holger F Rabenau; Sandra Ciesek; Bernhard K Krämer; Uwe Göttmann; Felix Drüschler; Christine Keller; Daniela Rose; Carsten Blume; Michael Thomas; Niko Kohmer; Anne Lammert
Journal:  Transplant Direct       Date:  2022-10-14

5.  Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring.

Authors:  Lutz Liefeldt; Petra Glander; Jens Klotsche; Henriette Straub-Hohenbleicher; Klemens Budde; Bettina Eberspächer; Frank Friedersdorff; Fabian Halleck; Pia Hambach; Jörg Hofmann; Nadine Koch; Danilo Schmidt; Eva Schrezenmeier; Evelyn Seelow; Ulrike Weber; Bianca Zukunft; Kai-Uwe Eckardt; Mira Choi; Friederike Bachmann; Johannes Waiser
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

6.  COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.

Authors:  George E Fragoulis; Vassiliki-Kalliopi Bournia; Eugenia Mavrea; Gerasimos Evangelatos; Kalliopi Fragiadaki; Anastasios Karamanakos; Eyrydiki Kravariti; Katerina Laskari; Stylianos Panopoulos; Maria Pappa; Dimos D Mitsikostas; Maria G Tektonidou; Dimitrios Vassilopoulos; Petros P Sfikakis
Journal:  Rheumatol Int       Date:  2021-11-05       Impact factor: 2.631

7.  Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal.

Authors:  Caoilfhionn M Connolly; Julie J Paik
Journal:  Lancet Rheumatol       Date:  2022-03-17

8.  Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

Authors:  Leanne P M van Leeuwen; Corine H GeurtsvanKessel; Pauline M Ellerbroek; Godelieve J de Bree; Judith Potjewijd; Abraham Rutgers; Hetty Jolink; Frank van de Veerdonk; Eric C M van Gorp; Faye de Wilt; Susanne Bogers; Lennert Gommers; Daryl Geers; Anke H W Bruns; Helen L Leavis; Jelle W van Haga; Bregtje A Lemkes; Annelou van der Veen; S F J de Kruijf-Bazen; Pieter van Paassen; Karina de Leeuw; Annick A J M van de Ven; Petra H Verbeek-Menken; Annelies van Wengen; Sandra M Arend; Anja J Ruten-Budde; Marianne W van der Ent; P Martin van Hagen; Rogier W Sanders; Marloes Grobben; Karlijn van der Straten; Judith A Burger; Meliawati Poniman; Stefan Nierkens; Marit J van Gils; Rory D de Vries; Virgil A S H Dalm
Journal:  J Allergy Clin Immunol       Date:  2022-04-11       Impact factor: 14.290

9.  Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine.

Authors:  Peter Schnuelle; Sebastian Kölling; Alexander Müller; Wilhelm H Schmitt
Journal:  Clin Kidney J       Date:  2021-12-23

Review 10.  COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.

Authors:  Rebecca Grainger; Alfred H J Kim; Richard Conway; Jinoos Yazdany; Philip C Robinson
Journal:  Nat Rev Rheumatol       Date:  2022-02-25       Impact factor: 32.286
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.